BriaCell Receives FDA Authorization to Initiate Phase I/IIa Trial of Cell-Based Immunotherapy BriaVax(TM) in Advanced Breast Cancer Patients
November 4, 2015
BriaCell Therapeutics Corp. November 4, 2015 11:01 AM BERKELEY, CA and VANCOUVER, BC–(Marketwired – November ...